Lam Research (NASDAQ:LRCX) Price Target Raised to $280.00

Lam Research (NASDAQ:LRCX) had its target price boosted by Argus from $175.00 to $280.00 in a research note released on Tuesday morning, MarketBeat reports.

Other equities research analysts also recently issued reports about the company. Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 price target (up from $175.00) on shares of Lam Research in a report on Monday, December 15th. Morgan Stanley upped their target price on shares of Lam Research from $211.00 to $244.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 29th. New Street Research upped their target price on Lam Research from $195.00 to $235.00 and gave the stock a “neutral” rating in a report on Friday, January 30th. Citigroup upped their target price on Lam Research from $265.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday, January 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $320.00 target price (up from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $243.32.

Lam Research Trading Up 1.7%

LRCX stock opened at $213.31 on Tuesday. Lam Research has a 1-year low of $56.32 and a 1-year high of $251.87. The business has a 50 day simple moving average of $192.85 and a two-hundred day simple moving average of $149.41. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The company has a market capitalization of $266.38 billion, a price-to-earnings ratio of 43.71, a PEG ratio of 2.27 and a beta of 1.78.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.17 by $0.10. The business had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts anticipate that Lam Research will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Insider Buying and Selling at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.31% of the company’s stock.

Hedge Funds Weigh In On Lam Research

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. PMV Capital Advisers LLC acquired a new stake in shares of Lam Research during the 4th quarter worth approximately $25,000. IMG Wealth Management Inc. acquired a new position in Lam Research in the second quarter valued at approximately $26,000. Stance Capital LLC purchased a new position in Lam Research in the third quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter valued at $27,000. Finally, Triumph Capital Management acquired a new position in shares of Lam Research in the 3rd quarter valued at $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Board approves quarterly dividend of $0.26/share — adds a cash-return component that signals confidence in cash flow and can support the stock as income-focused investors re-evaluate the name. Lam Research Corporation Declares Quarterly Dividend
• Positive Sentiment: Analyst upgrades and big price-target hikes — Argus raised its target to $280 and several outlets report materially higher targets (one report shows target ~ $271), which lifts conviction among growth investors and likely triggered buying/rehypothecation by funds tracking analyst sentiment. Argus Increases Lam Research (NASDAQ:LRCX) Price Target to $280.00
• Positive Sentiment: Strategic tech alliance targets AI equipment edge — Lam’s collaboration with CEA‑Leti to pursue AI-focused equipment strengthens its exposure to the highest-growth end markets (AI datacenter chips), supporting longer-term revenue upside. Lam Research Leadership And CEA Leti Alliance Target AI Equipment Edge
• Positive Sentiment: High-profile buy guidance from media — Jim Cramer suggested layering into Lam, which can drive short-term retail and momentum flows into the stock. Jim Cramer on Lam Research: “Put a Quarter of the Position on It If You Want to Buy Lam Research, and Then Leg In”
• Neutral Sentiment: Board addition and COO transition announced — management changes can be positive if they improve execution, but investors will watch the transition closely for continuity and any signaling in guidance or capital allocation. Lam Research Announces Board Addition and COO Transition
• Neutral Sentiment: Analyst/market commentary highlights upside but notes recent volatility — coverage from Zacks and Forbes points to strong fundamentals and sizable modeled upside, while also noting a recent pullback that increases near-term volatility risk. Wall Street Analysts Believe Lam Research (LRCX) Could Rally 30.51%: Here’s is How to Trade

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.